Access to anti-retroviral drugs, female (%) in Eritrea
Eritrea: Access to anti-retroviral drugs, female (%) was 72.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Eritrea, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
Eritrea recorded 72.0% for access to anti-retroviral drugs, female in 2024. That is the highest value across all 25 years on record.
Compared with earlier readings it is up 44.0% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Eritrea peaked at 72.0% in 2023 and was at its lowest, 0.0%, in 2000.
Eritrea ranks 76th of 141 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female (%) in Eritrea, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 2.0% | — |
| 2006 | 5.0% | +150.0% |
| 2007 | 10.0% | +100.0% |
| 2008 | 14.0% | +40.0% |
| 2009 | 18.0% | +28.6% |
| 2010 | 25.0% | +38.9% |
| 2011 | 32.0% | +28.0% |
| 2012 | 37.0% | +15.6% |
| 2013 | 43.0% | +16.2% |
| 2014 | 50.0% | +16.3% |
| 2015 | 56.0% | +12.0% |
| 2016 | 58.0% | +3.6% |
| 2017 | 66.0% | +13.8% |
| 2018 | 68.0% | +3.0% |
| 2019 | 69.0% | +1.5% |
| 2020 | 71.0% | +2.9% |
| 2021 | 70.0% | -1.4% |
| 2022 | 71.0% | +1.4% |
| 2023 | 72.0% | +1.4% |
| 2024 | 72.0% | +0.0% |
Eritrea compared with similar countries
- Eritrea's 72.0% is below the median for low income countries, which is 75.5%, 95% of the median. (24 countries reporting)
- Eritrea's 72.0% is below the median for Sub-Saharan Africa, which is 88.5%, 81% of the median. (44 countries reporting)
Biggest year-on-year movements
Years where Access to anti-retroviral drugs, female (%) in Eritrea changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2006 | +150.0% | 2.0% | 5.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 4.9% | 0.0% | 18.0% | 10 |
| 2010s | 50.4% | 25.0% | 69.0% | 10 |
| 2020s | 71.2% | 70.0% | 72.0% | 5 |
Countries ranked near Eritrea
More gender data for Eritrea
- Child population (UN estimates and projections) 1,428 (2030)
- Child population (UN estimates and projections) (0-14), annual growth 1.34 % change on previous year (2030)
- Population 2,575 (2030)
- Working-age population (UN estimates and projections) 2,575 (2030)
- Population (UN estimates and projections), annual growth rate 2.52 % change on previous year (2030)
- Age population, age 00, female, interpolated 49,309 (2025)
- Age population, age 00, male, interpolated 50,569 (2025)
- Age population, age 01, female, interpolated 47,954 (2025)
- Age population, age 01, male, interpolated 49,112 (2025)
- Age population, age 02, female, interpolated 46,799 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Eritrea?
- Access to anti-retroviral drugs, female in Eritrea was 72.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Eritrea?
- The highest recorded value was 72.0% in 2023.
- What is the lowest access to anti-retroviral drugs, female recorded in Eritrea?
- The lowest recorded value was 0.0% in 2000.
- How does Eritrea rank for access to anti-retroviral drugs, female?
- Eritrea ranks 76th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Eritrea?
- Over the last ten years it is up 44.0%. The long-run trend across the full record is volatile.
- Where does this Eritrea data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.